Shots: The company will apply its unique structure-based drug design platform and capabilities to the global research efforts to discover drugs targeting COVID-19 Sosei Heptares has initiated a new R&D program to identify compounds blocking the activity of SARS-CoV-2 MPro protease (Nsp5), which has been designated as a potential target for drug development The company […]Read More
